Announcements Trials
Browse Landscape

Phase

Phase 2 52Phase 3 23Phase 1 11Phase 1/2 8Phase NA 4Phase 4 4Phase 2/3 1

Status

Unknown 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 4Other solid neoplasm 1Gynecologic 1CNS 1

Conditions

Adenocarcinoma of Lung 2Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder) 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 44Radiosurgery 41Early Intervention, Educational 34Standard of Care 32Educational Status 31Exercise 30Methods 29Drug Therapy 26Radiotherapy 23Magnetic Resonance Spectroscopy 23Practice Guidelines as Topic 22Surveys and Questionnaires 21X-Rays 17Pemetrexed 17Carboplatin 16Biopsy 16Tomography, X-Ray Computed 14Thoracic Surgery, Video-Assisted 14Therapeutics 12Interviews as Topic 12Fluorodeoxyglucose F18 12Gefitinib 11Cisplatin 11Specimen Handling 10Patient Navigation 10Cryosurgery 10Anterior Temporal Lobectomy 10anlotinib 9Surgical Procedures, Operative 9Psychiatric Rehabilitation 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × tislelizumab × Thoracic × Clear all
NCT06607926 2024-09-23

Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLC

Xuanwu Hospital, Beijing

Phase NA Not yet recruiting
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06154967 2023-12-04

To Explore the Effect of Immune-induced Stereotactic Body Radiotherapy (SBRT) on Reversing Immunoresistance in Stage IIIc/IV Non-small Cell Lung Cancer (NSCLC)

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Phase NA Unknown
20 enrolled
Thoracic

Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder)

NCT06056115 2023-09-28

Efficacy and Safety of Tislelizumab for Lung Adenocarcinoma With Asymptomatic Brain Metastatic

Hebei Medical University Fourth Hospital

Phase NA Recruiting
20 enrolled
Thoracic

Adenocarcinoma of Lung

NCT05527808 2023-06-08

A Single-arm Exploratory Study of Neoadjuvant Therapy

Guangzhou Institute of Respiratory Disease

Phase NA Unknown
28 enrolled
Thoracic

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡